Enteris BioPharma provides total integrated CMC service support, including pre-formulation, formulation, analytical research and development, quality assurance, and clinical and commercial manufacturing of solid, oral dosage forms while keeping our partner’s product vision the highest priority. We have a new purpose-built, state-of-the-art facility equipped to handle myriad active pharmaceutical ingredients (APIs), including dedicated processing and containment areas for high potency active pharmaceutical ingredients (HPAPIs).
 

Our CDMO operations are housed within a 32,000-square-foot (2,970 square meters), FDA-inspected and cGMP-compliant facility in northern New Jersey comprised of an unparalleled team of industry-leading subject matter experts with robust institutional experience, project management, and rapid problem-solving expertise.

• U.S.-based production and supply chain
• 32,000-square-foot (2,970 square meters), new purpose-built, state-of-the-art, cGMP facility
• 1,700 square feet (160 square meters) of flexible suite space enabling Enteris to adapt to our partner’s development and manufacturing campaign needs
• 2,500 square feet (230 square meters) dedicated to HPAPI powder handling
• Total integrated CMC service support across pharmaceutical development life cycle

DOWNLOAD OUR BROCHURE TO LEARN MORE >>>>>